FDA Ponders Drug Pricing In Opioid Abuse Analysis
The agency, of course, cannot consider drug pricing in approval decisions, but is making itself aware as it mulls broader policy changes.
The agency, of course, cannot consider drug pricing in approval decisions, but is making itself aware as it mulls broader policy changes.